A recent study reported that combined CDK7/12/13 inhibition with THZ1 and BRD4 inhibition overcomes enhancer reprogramming in BET inhibitor-resistant leukemia cells and consequently suppresses oncogenic transcription (35). Here, CDK7 is linked to leukemia.